Literature DB >> 23398380

Radiocesium in Pacific bluefin tuna Thunnus orientalis in 2012 validates new tracer technique.

Daniel J Madigan1, Zofia Baumann, Owyn E Snodgrass, Halim A Ergül, Heidi Dewar, Nicholas S Fisher.   

Abstract

The detection of Fukushima-derived radionuclides in Pacific bluefin tuna (PBFT) that crossed the Pacific Ocean to the California Current Large Marine Ecosystem (CCLME) in 2011 presented the potential to use radiocesium as a tracer in highly migratory species. This tracer requires that all western Pacific Ocean emigrants acquire the (134)Cs signal, a radioisotope undetectable in Pacific biota prior to the Fukushima accident in 2011. We tested the efficacy of the radiocesium tracer by measuring (134)Cs and (137)Cs in PBFT (n = 50) caught in the CCLME in 2012, more than a year after the Fukushima accident. All small PBFT (n = 28; recent migrants from Japan) had (134)Cs (0.7 ± 0.2 Bq kg(-1)) and elevated (137)Cs (2.0 ± 0.5 Bq kg(-1)) in their white muscle tissue. Most larger, older fish (n = 22) had no (134)Cs and only background levels of (137)Cs, showing that one year in the CCLME is sufficient for (134)Cs and (137)Cs values in PBFT to reach pre-Fukushima levels. Radiocesium concentrations in 2012 PBFT were less than half those from 2011 and well below safety guidelines for public health. Detection of (134)Cs in all recent migrant PBFT supports the use of radiocesium as a tracer in migratory animals in 2012.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 23398380     DOI: 10.1021/es4002423

Source DB:  PubMed          Journal:  Environ Sci Technol        ISSN: 0013-936X            Impact factor:   9.028


  1 in total

1.  Evaluation of radiation doses and associated risk from the Fukushima nuclear accident to marine biota and human consumers of seafood.

Authors:  Nicholas S Fisher; Karine Beaugelin-Seiller; Thomas G Hinton; Zofia Baumann; Daniel J Madigan; Jacqueline Garnier-Laplace
Journal:  Proc Natl Acad Sci U S A       Date:  2013-06-03       Impact factor: 11.205

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.